CN113244152A - 一种白芨美肤修复护肤制剂及其制备方法和应用 - Google Patents
一种白芨美肤修复护肤制剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN113244152A CN113244152A CN202110661525.XA CN202110661525A CN113244152A CN 113244152 A CN113244152 A CN 113244152A CN 202110661525 A CN202110661525 A CN 202110661525A CN 113244152 A CN113244152 A CN 113244152A
- Authority
- CN
- China
- Prior art keywords
- skin
- parts
- bletilla striata
- beautifying
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001313857 Bletilla striata Species 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 53
- 239000000284 extract Substances 0.000 claims abstract description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 14
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 14
- 239000002738 chelating agent Substances 0.000 claims abstract description 14
- 239000003906 humectant Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 239000002562 thickening agent Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 241001076416 Dendrobium tosaense Species 0.000 claims description 27
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 18
- 235000006708 antioxidants Nutrition 0.000 claims description 13
- 241000219357 Cactaceae Species 0.000 claims description 12
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 11
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 11
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 11
- 235000020710 ginseng extract Nutrition 0.000 claims description 11
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 9
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 9
- 229940035437 1,3-propanediol Drugs 0.000 claims description 9
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 claims description 9
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 9
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- 229960000458 allantoin Drugs 0.000 claims description 9
- 229960003237 betaine Drugs 0.000 claims description 9
- 229960001631 carbomer Drugs 0.000 claims description 9
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 9
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 9
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 8
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 8
- 150000004676 glycans Chemical class 0.000 claims description 8
- 229920001282 polysaccharide Polymers 0.000 claims description 8
- 239000005017 polysaccharide Substances 0.000 claims description 8
- 230000008439 repair process Effects 0.000 claims description 8
- 239000004475 Arginine Substances 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 6
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 6
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 6
- 235000005152 nicotinamide Nutrition 0.000 claims description 6
- 239000011570 nicotinamide Substances 0.000 claims description 6
- 229960003966 nicotinamide Drugs 0.000 claims description 6
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 4
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- 239000007888 film coating Substances 0.000 claims description 2
- 238000009501 film coating Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 230000003020 moisturizing effect Effects 0.000 abstract description 15
- 230000002087 whitening effect Effects 0.000 abstract description 13
- 230000003750 conditioning effect Effects 0.000 abstract description 9
- 241000894006 Bacteria Species 0.000 abstract description 8
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 8
- 208000026935 allergic disease Diseases 0.000 abstract description 8
- 230000007815 allergy Effects 0.000 abstract description 8
- 230000003647 oxidation Effects 0.000 abstract description 8
- 238000007254 oxidation reaction Methods 0.000 abstract description 8
- 206010000496 acne Diseases 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 4
- 206010014970 Ephelides Diseases 0.000 abstract description 4
- 208000003351 Melanosis Diseases 0.000 abstract description 4
- 230000002421 anti-septic effect Effects 0.000 abstract description 4
- 238000004945 emulsification Methods 0.000 abstract description 4
- 230000014759 maintenance of location Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 239000013078 crystal Substances 0.000 abstract 1
- 230000003325 follicular Effects 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 42
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 11
- 239000000686 essence Substances 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 238000003809 water extraction Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- -1 caprylyl hydroxamic Chemical compound 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003246 corticosteroid Substances 0.000 description 3
- 238000005562 fading Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明属于化妆品技术领域，公开了一种白芨美肤修复护肤制剂及其制备方法和应用。该制剂是以白芨根水和白芨根提取物作保湿剂、皮肤调理剂，用于调理皮肤、保湿和美白祛斑；再次加入保湿剂，用于抗菌和进一步提高保湿力度；皮肤调理剂用于抗氧化、舒敏；混合抗氧化剂和溶剂，实现对皮肤保湿调理、抗衰老、抗氧化、祛痘、舒敏抗炎、美白淡斑、抗菌收敛毛孔，提升肌肤晶透力，润透补水、令肌肤莹亮透白，光滑细腻。增稠剂、调节剂和螯合剂加入，提高各原料间乳化程度，提高稳定性。上述未添加任何香精和防腐剂，适用于所有人群使用。流程简单，操作设备少，对操作人员要求不高且成本低廉。该制剂安全可靠，无任何毒副作用，适合工厂进行大量生产。
Description
技术领域
本发明属于化妆品技术领域，具体涉及一种白芨美肤修复护肤制剂及其制备方法和应用。
背景技术
有句俗话说：一白遮百丑。现在人对美的一个评判标准是皮肤白皙透亮。于是，很多女性朋友为了美白，花费了不少的心思，尝试了各种各样的美白护肤方法，但是效果多数都不尽人意。有些人还以为乱用美白护肤品导致皮肤过敏了。
随着经济的发展，工作、生活节奏越来越快，精神压力越来越大，加上不良的生活习惯、恶劣环境、紫外线、不正确的皮肤护理等众多因素对皮肤的伤害，越来越多的人都被干燥、粗糙、没弹性、肤色黯哑、满脸倦容、粗糙、毛孔粗大等皮肤状况紊乱的综合问题困扰，虽然市场上的护肤品非常丰富，但面对这种综合性问题总不能够很好的解决，常常解决了一方面的问题同时又加深了另一方面的问题。
目前市面上有很多用于焕颜美白护肤的产品，这些产品均具有一定的美白、皮肤调理和皮肤修护的功效。
但是大部分护肤产品主要成分采用化工合成成分，如甲基葡糖醇聚醚-20、丁二醇、甘油等，活性提取物含量偏低，针对皮肤细胞活性的修护效果不佳，并且许多护肤品中添加有防腐剂、香精或其他孕妇慎用的成分，提高了使用的风险。
发明内容
为了解决现有技术存在的上述问题，本发明目的在于提供一种白芨美肤修复护肤制剂及其制备方法和应用。
本发明所采用的技术方案为：一种白芨美肤修复护肤制剂，所述制剂主要由以下质量份数的原料制备得到：
白芨根水50-200份，白芨根提取物50-200份，保湿剂85-220份，皮肤调理剂27-70份，抗氧化剂11-45份，增稠剂1-5份，调节剂0.5-2.5份，螯合剂0.75-3.75份和溶剂300-1200份。
上述提供了一种白芨美肤修复护肤制剂，该制剂是以白芨根水和白芨根提取物作保湿剂、皮肤调理剂，用于调理皮肤、保湿、去黑头、抗衰老和美白祛斑；加之再次加入保湿剂，用于抗菌和进一步提高保湿力度；皮肤调理剂用于抗氧化、舒敏；混合抗氧化剂和溶剂，进而实现了对皮肤保湿调理、抗衰老、抗氧化、祛痘、舒敏抗炎、美白淡斑、抗菌收敛毛孔的功效，而且增稠剂、调节剂和螯合剂的加入，提高了各原料间的乳化程度，提高稳定性和安全性。上述未添加任何香精和防腐剂，适用于所有人群使用。
作为优选地，所述制剂主要由以下质量份数的原料制备得到：
白芨根水80-150份，白芨根提取物80-150份，保湿剂110-190份，皮肤调理剂35-60份，抗氧化剂18-34份，增稠剂1.6-3份，调节剂0.8-1.5份，螯合剂1.2-2.25份和溶剂480-900份。
白芨根水的提取方法为选取白芨根作为原料，采用水提的方式获得。
作为优选地，所述制剂主要由以下质量份数的原料制备得到：
白芨根水100份，白芨根提取物100份，保湿剂135份，皮肤调理剂43份，抗氧化剂22份，增稠剂2份，调节剂1份，螯合剂1.5份和溶剂600份。
作为优选地，所述白芨根提取物为白芨多糖；
所述保湿剂包括丁二醇、甘油聚醚-26、1,2-己二醇、1,3-丙二醇和甜菜碱的混合物；
丁二醇、甘油聚醚-26、1,2-己二醇、1,3-丙二醇和甜菜碱的质量体积比为1-10：0.2-2：0.05-0.5：0.05-0.5：0.05-0.5；
所述皮肤调理剂包括仙人掌提取物、烟酰胺、铁皮石斛茎提取物、甘草酸二钾和尿囊素；
仙人掌提取物、烟酰胺、铁皮石斛茎提取物、甘草酸二钾和尿囊素的质量体积比为1-2:1-2:0.05-0.1：0.05-0.1：0.05-0.1。
白芨根提取物，即为白芨多糖，其为由白芨块茎，采用醇提的方式，提取精制而成的白芨多糖，具有优秀的保湿效果，能够在皮肤表面形成一层均匀的薄膜，独特的肤感，可以激活皮肤细胞，增强皮肤免疫功能，促进胶原蛋白生成，加快皮肤修复，用于基础保湿护理、敏感肌肤护理、皮肤修复抗衰老。
仙人掌提取物的提取方法为选取仙人掌作为原料，采用水提的方式获得。
铁皮石斛茎提取物的提取方法为选取铁皮石斛茎作为原料，采用水提的方式获得。
烟酰胺，是一种水溶性维生素且是维生素B族中的一员。烟酸可以在活体内被转变为烟酰胺，尽管这两种化合物都具有维生素效应，但烟酰胺较烟酸的药理学与毒性要小，这些效应会在烟酸的转变过程中产生。因此烟酰胺也不会像烟酸一样减少胆固醇或导致脸潮红。当成人每天摄入剂量多于3g时，会对肝脏产生毒性。在细胞中，烟酸被用于合成烟酰胺腺嘌呤二核苷酸(NAD)与烟酰胺腺嘌呤二核苷酸磷酸(NADP)，而对于烟酰胺来说转变途径与烟酸的途径非常相似。NAD+与NADP+是多种酶促氧化还原反应的辅酶。
铁皮石斛，(学名：Dendrobiumofficinale Kimura et Migo)，中药名。为兰科植物铁皮石斛Dendrobiumofficinale Kimura et Migo的干燥茎。具有益胃生津，滋阴清热的功效。主治热病津伤，口干烦渴，胃阴不足，食少干呕，病后虚热不退，阴虚火旺，骨蒸劳热，目暗不明，筋骨痿软。
甘草酸二钾，为白色或类白色细粉末，纯度达98％，有特殊甜味，水溶好、口感纯。甘草酸二钾具有抑菌、消炎、解毒、抗敏、除臭等多种功效。在医药、化妆品日化、食品等行业有广泛的应用。可用于眼药水、口腔炎的药膏。可活化皮质甾类化合物(抑制代谢酶)。间接增强皮质甾类化合物的作用，可用于膏、霜、水、乳液、奶类和蜜类等所有化妆品，它可以中和或减低化妆品的有毒物质，也可以防止有的化妆品的过敏反应，更适合用于高级发用或用于化妆品中，市场上的规格为UV≥98％，HPLC≥76％(指甘草酸的有效成分)。
作为优选地，所述抗氧化剂包括人参提取物、铁皮石斛提取物和3-o-乙基抗坏血酸；
人参提取物、铁皮石斛提取物和3-o-乙基抗坏血酸的质量体积比为1-2:0.05-0.1:0.05-0.1；
所述增稠剂包括卡波姆和黄原胶；
卡波姆和黄原胶的质量体积比为1-2:1-2；
所述调节剂包括精氨酸。
人参提取物的提取方法为选取人参作为原料，采用水提的方式获得。
铁皮石斛提取物的提取方法为选取铁皮石斛作为原料，采用水提的方式获得。
作为优选地，所述螯合剂包括辛酰羟肟酸和EDTA二钠；辛酰羟肟酸和EDTA二钠的质量体积比为1-2：0.5-0.05。
作为优选地，所述溶剂为去离子水。
一种白芨美肤修复护肤制剂的制备方法，所述制备方法包括按照相应比例选取白芨根水、白芨根提取物、保湿剂、皮肤调理剂、抗氧化剂、增稠剂、调节剂、螯合剂和溶剂混匀后，获得成品。
上述该制剂的制备方法流程简单，操作设备少，对操作人员要求不高且成本低廉。该制剂安全可靠，无任何毒副作用，适合工厂进行大量生产。
作为优选地，所述成品包括液体剂、凝胶剂、涂膜剂和乳膏剂中的任意一种。
一种白芨美肤修复护肤制剂的应用，所述白芨美肤修复护肤制剂在护肤化妆品中的应用。
本发明的有益效果为：
本发明提供了一种白芨美肤修复护肤制剂，该制剂是以白芨根水和白芨根提取物作保湿剂、皮肤调理剂，用于调理皮肤、保湿、去黑头、抗衰老和美白祛斑；加之再次加入保湿剂，用于抗菌和进一步提高保湿力度；皮肤调理剂用于抗氧化、舒敏；混合抗氧化剂和溶剂，进而实现了对皮肤保湿调理、抗衰老、抗氧化、祛痘、舒敏抗炎、美白淡斑、抗菌收敛毛孔，提升肌肤晶透力，润透补水、令肌肤莹亮透白，光滑细腻。而且增稠剂、调节剂和螯合剂的加入，提高了各原料间的乳化程度，提高稳定性和安全性。上述未添加任何香精和防腐剂，适用于所有人群使用。流程简单，操作设备少，对操作人员要求不高且成本低廉。该制剂安全可靠，无任何毒副作用，适合工厂进行大量生产。
具体实施方式
下面结合具体实施例对本发明做进一步阐释。本领域技术人员将会理解，下列所描述的实施例是本发明一部分实施例，而不是全部的实施例，仅用于说明本发明，而不应视为限制本发明的范围。所用试剂均为可以通过市售购买获得的常规产品。
实施例1：
一种白芨美肤修复护肤制剂的制备方法，包括按照相应比例选取白芨根水500克、白芨多糖500克、丁二醇629.6克、甘油聚醚-26 125.9克、1,2-己二醇31.5克、1,3-丙二醇31.5克、甜菜碱31.5克、仙人掌提取物125.6克、烟酰胺125.6克、铁皮石斛茎提取物6.28克、甘草酸二钾6.28克、尿囊素6.28克、人参提取物100克、铁皮石斛提取物5克、3-o-乙基抗坏血酸5克、卡波姆5克、黄原胶5克、精氨酸5克、辛酰羟肟酸5克、EDTA二钠2.5克和去离子水3000克混匀后，获得成品。
实施例2：
一种白芨美肤修复护肤制剂的制备方法，包括按照相应比例选取白芨根水2000克、白芨多糖2000克、丁二醇1629.6克、甘油聚醚-26 325.9克、1,2-己二醇81.48克、1,3-丙二醇81.48克、甜菜碱81.48克、仙人掌提取物325.6克、烟酰胺325.6克、铁皮石斛茎提取物16.3克、甘草酸二钾16.3克、尿囊素16.3克、人参提取物409.1克、铁皮石斛提取物20.45克、3-o-乙基抗坏血酸20.45克、卡波姆25克、黄原胶25克、精氨酸25克、辛酰羟肟酸36.6克、EDTA二钠0.91克和去离子水12000克混匀后，获得成品。
实施例3：
一种白芨美肤修复护肤制剂的制备方法，包括按照相应比例选取白芨根水800克、白芨多糖800克、丁二醇814.8克、甘油聚醚-26 162.9克、1,2-己二醇40.7克、1,3-丙二醇40.7克、甜菜碱40.7克、仙人掌提取物162.8克、烟酰胺162.8克、铁皮石斛茎提取物8.14克、甘草酸二钾8.14克、尿囊素8.14克、人参提取物163.6克、铁皮石斛提取物8.18克、3-o-乙基抗坏血酸8.18克、卡波姆8克、黄原胶8克、精氨酸8克、辛酰羟肟酸8克、EDTA二钠2.5克和去离子水4800克混匀后，获得成品。
实施例4：
一种白芨美肤修复护肤制剂的制备方法，包括按照相应比例选取白芨根水1500克、白芨多糖1500克、丁二醇1407.4克、甘油聚醚-26 281.5克、1,2-己二醇70.37克、1,3-丙二醇70.37克、甜菜碱70.37克、仙人掌提取物279.1克、烟酰胺279.1克、铁皮石斛茎提取物13.95克、甘草酸二钾13.95克、尿囊素13.95克、人参提取物309.1克、铁皮石斛提取物15.45克、3-o-乙基抗坏血酸15.45克、卡波姆15克、黄原胶15克、精氨酸15克、辛酰羟肟酸36.6克、EDTA二钠0.92克和去离子水9000克混匀后，获得成品。
实施例5：
一种白芨美肤修复护肤制剂的制备方法，包括按照相应比例选取白芨根水1000克、白芨多糖1000克、丁二醇1000克、甘油聚醚-26 200克、1,2-己二醇50克、1,3-丙二醇50克、甜菜碱50克、仙人掌提取物200克、烟酰胺200克、铁皮石斛茎提取物10克、甘草酸二钾10克、尿囊素10克、人参提取物200克、铁皮石斛提取物10克、3-o-乙基抗坏血酸10克、卡波姆10克、黄原胶10克、精氨酸10克、辛酰羟肟酸10克、EDTA二钠2.5克和去离子水6000克混匀后，获得成品。
实验例
实验组：选用上述实施例5制备得到的成品为液体状，将市售的压缩面膜浸泡其中后，以面膜的方式进行实验。
对照组：为市售的白芨鲜养神经酰胺修护面膜。
对比指标：功效对比、安全评分对比、成分对比。
对比数据结果：
功效对比：
安全评分对比：
| 实验组 | 对照组 | |
| 香精 | 无 | 无 |
| 防腐剂 | 无 | 1种 |
| 风险成分 | 无 | 无 |
| 孕妇慎用 | 无 | 无 |
| 安全分 | 5分 | 4.5分 |
成分对比：
综上所述数据显示，本申请的白芨美肤修复护肤制剂更安全、各类功效成分均较多，且无防腐剂等。
本发明提供了一种白芨美肤修复护肤制剂，该制剂是以白芨根水和白芨根提取物作保湿剂、皮肤调理剂，用于调理皮肤、保湿、去黑头、抗衰老和美白祛斑；加之再次加入保湿剂，用于抗菌和进一步提高保湿力度；皮肤调理剂用于抗氧化、舒敏；混合抗氧化剂和溶剂，进而实现了对皮肤保湿调理、抗衰老、抗氧化、祛痘、舒敏抗炎、美白淡斑、抗菌收敛毛孔，提升肌肤晶透力，润透补水、令肌肤莹亮透白，光滑细腻。而且增稠剂、调节剂和螯合剂的加入，提高了各原料间的乳化程度，提高稳定性和安全性。上述未添加任何香精和防腐剂，适用于所有人群使用。流程简单，操作设备少，对操作人员要求不高且成本低廉。该制剂安全可靠，无任何毒副作用，适合工厂进行大量生产。
本发明不局限于上述可选的实施方式，任何人在本发明的启示下都可得出其他各种形式的产品，均属于本发明的保护范围。上述具体实施方式不应理解成对本发明的保护范围的限制，本领域的普通技术人员应当理解，在不背离本发明的范围下，可对前述各实施例所记载的技术方案进行修改，或对其中部分或者全部技术特征进行等同替换，与此同时这些修改或者替换，并不会使相应的技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (10)
1.一种白芨美肤修复护肤制剂，其特征在于，所述制剂主要由以下质量份数的原料制备得到：
白芨根水50-200份，白芨根提取物50-200份，保湿剂85-220份，皮肤调理剂27-70份，抗氧化剂11-45份，增稠剂1-5份，调节剂0.5-2.5份，螯合剂0.75-3.75份和溶剂300-1200份。
2.根据权利要求1所述的一种白芨美肤修复护肤制剂，其特征在于，所述制剂主要由以下质量份数的原料制备得到：
白芨根水80-150份，白芨根提取物80-150份，保湿剂110-190份，皮肤调理剂35-60份，抗氧化剂18-34份，增稠剂1.6-3份，调节剂0.8-1.5份，螯合剂1.2-2.25份和溶剂480-900份。
3.根据权利要求2所述的一种白芨美肤修复护肤制剂，其特征在于，所述制剂主要由以下质量份数的原料制备得到：
白芨根水100份，白芨根提取物100份，保湿剂135份，皮肤调理剂43份，抗氧化剂22份，增稠剂2份，调节剂1份，螯合剂1.5份和溶剂600份。
4.根据权利要求1-3任一所述的一种白芨美肤修复护肤制剂，其特征在于，所述白芨根提取物为白芨多糖；
所述保湿剂包括丁二醇、甘油聚醚-26、1,2-己二醇、1,3-丙二醇和甜菜碱的混合物；
丁二醇、甘油聚醚-26、1,2-己二醇、1,3-丙二醇和甜菜碱的质量体积比为1-10：0.2-2：0.05-0.5：0.05-0.5：0.05-0.5；
所述皮肤调理剂包括仙人掌提取物、烟酰胺、铁皮石斛茎提取物、甘草酸二钾和尿囊素；
仙人掌提取物、烟酰胺、铁皮石斛茎提取物、甘草酸二钾和尿囊素的质量体积比为1-2:1-2:0.05-0.1：0.05-0.1：0.05-0.1。
5.根据权利要求1-3任一所述的一种白芨美肤修复护肤制剂，其特征在于，所述抗氧化剂包括人参提取物、铁皮石斛提取物和3-o-乙基抗坏血酸；
人参提取物、铁皮石斛提取物和3-o-乙基抗坏血酸的质量体积比为1-2:0.05-0.1:0.05-0.1；
所述增稠剂包括卡波姆和黄原胶；
卡波姆和黄原胶的质量体积比为1-2:1-2；
所述调节剂包括精氨酸。
6.根据权利要求1-3任一所述的一种白芨美肤修复护肤制剂，其特征在于，所述螯合剂包括辛酰羟肟酸和EDTA二钠；辛酰羟肟酸和EDTA二钠的质量体积比为1-2：0.5-0.05。
7.根据权利要求1-3任一所述的一种白芨美肤修复护肤制剂，其特征在于，所述溶剂为去离子水。
8.一种如权利要求1-7任一所述的白芨美肤修复护肤制剂的制备方法，其特征在于，所述制备方法包括按照相应比例选取白芨根水、白芨根提取物、保湿剂、皮肤调理剂、抗氧化剂、增稠剂、调节剂、螯合剂和溶剂混匀后，获得成品。
9.根据权利要求8所述的一种白芨美肤修复护肤制剂的制备方法，其特征在于，所述成品包括液体剂、凝胶剂、涂膜剂和乳膏剂中的任意一种。
10.一种如权利要求1-7任一所述的白芨美肤修复护肤制剂的应用，其特征在于，所述白芨美肤修复护肤制剂在护肤化妆品中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110661525.XA CN113244152A (zh) | 2021-06-15 | 2021-06-15 | 一种白芨美肤修复护肤制剂及其制备方法和应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110661525.XA CN113244152A (zh) | 2021-06-15 | 2021-06-15 | 一种白芨美肤修复护肤制剂及其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113244152A true CN113244152A (zh) | 2021-08-13 |
Family
ID=77187942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110661525.XA Pending CN113244152A (zh) | 2021-06-15 | 2021-06-15 | 一种白芨美肤修复护肤制剂及其制备方法和应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113244152A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114404321A (zh) * | 2022-01-29 | 2022-04-29 | 广州栋方生物科技股份有限公司 | 一种白及多糖稳定性溶液体系及其制备方法和应用 |
| CN115300402A (zh) * | 2022-08-22 | 2022-11-08 | 广州药妆日用化工有限公司 | 一种抗敏舒缓修复乳液及其制备方法 |
| CN116712362A (zh) * | 2023-06-19 | 2023-09-08 | 天津中医药大学 | 一种高稳定、易吸收的党参凝胶面膜及其制备方法 |
| CN117243877A (zh) * | 2023-10-23 | 2023-12-19 | 上海创元化妆品有限公司 | 一种含有白芨提取物的化妆品组合物及其制备方法与应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108969446A (zh) * | 2018-10-10 | 2018-12-11 | 福建省梦娇兰日用化学品有限公司 | 一种增强皮肤屏障功能的婴幼儿防皴护肤组合物及其制备方法 |
| CN110755348A (zh) * | 2019-11-27 | 2020-02-07 | 邹杰 | 一种护肤组合物及其制备方法 |
| CN111514087A (zh) * | 2020-05-21 | 2020-08-11 | 上海江笙生物科技有限公司 | 一种美白亮肤组合物及其制备方法 |
| CN111888318A (zh) * | 2020-09-23 | 2020-11-06 | 张莉 | 一种皮肤修复、美白祛痘面膜及其制备方法 |
| CN112494404A (zh) * | 2020-12-25 | 2021-03-16 | 西南林业大学 | 一种铁皮石斛嫩肤修护补水面膜及其制备方法 |
-
2021
- 2021-06-15 CN CN202110661525.XA patent/CN113244152A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108969446A (zh) * | 2018-10-10 | 2018-12-11 | 福建省梦娇兰日用化学品有限公司 | 一种增强皮肤屏障功能的婴幼儿防皴护肤组合物及其制备方法 |
| CN110755348A (zh) * | 2019-11-27 | 2020-02-07 | 邹杰 | 一种护肤组合物及其制备方法 |
| CN111514087A (zh) * | 2020-05-21 | 2020-08-11 | 上海江笙生物科技有限公司 | 一种美白亮肤组合物及其制备方法 |
| CN111888318A (zh) * | 2020-09-23 | 2020-11-06 | 张莉 | 一种皮肤修复、美白祛痘面膜及其制备方法 |
| CN112494404A (zh) * | 2020-12-25 | 2021-03-16 | 西南林业大学 | 一种铁皮石斛嫩肤修护补水面膜及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 郑州丹草中医药研究院有限公司: "《国产非特殊用途化妆品备案服务平台》", 25 August 2020, pages: 2 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114404321A (zh) * | 2022-01-29 | 2022-04-29 | 广州栋方生物科技股份有限公司 | 一种白及多糖稳定性溶液体系及其制备方法和应用 |
| CN114404321B (zh) * | 2022-01-29 | 2024-01-02 | 广州栋方生物科技股份有限公司 | 一种白及多糖稳定性溶液体系及其制备方法和应用 |
| CN115300402A (zh) * | 2022-08-22 | 2022-11-08 | 广州药妆日用化工有限公司 | 一种抗敏舒缓修复乳液及其制备方法 |
| CN116712362A (zh) * | 2023-06-19 | 2023-09-08 | 天津中医药大学 | 一种高稳定、易吸收的党参凝胶面膜及其制备方法 |
| CN117243877A (zh) * | 2023-10-23 | 2023-12-19 | 上海创元化妆品有限公司 | 一种含有白芨提取物的化妆品组合物及其制备方法与应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113244152A (zh) | 一种白芨美肤修复护肤制剂及其制备方法和应用 | |
| CN107496245B (zh) | 一种抗衰老脂质体组合物及其制备方法和应用 | |
| CN105078875B (zh) | 一种含牡丹提取物的化妆品及其制备方法 | |
| CN101129308A (zh) | 一种纳米银美容面膜 | |
| CN105476950B (zh) | 保湿泡沫洁面乳及其制备方法 | |
| CN110693780A (zh) | 滋养肌肤组合物及其应用、滋养肌肤面膜液 | |
| CN107693456A (zh) | 一种天然茶油面霜及其制备方法 | |
| CN113018238A (zh) | 一种抑菌消炎清爽益肤的祛痘凝胶及其制备方法 | |
| CN107714587A (zh) | 一种天然茶油护肤乳液及其制备方法 | |
| CN103550128B (zh) | 一种美肌水肤凝露及其制备方法 | |
| CN108245454B (zh) | 一种含有天然抗氧化成分的温和洁面膏及其制备方法 | |
| CN115517982A (zh) | 一种白芨祛痘修护凝胶及其制备方法 | |
| CN115068385A (zh) | 一种美白精华液及其制备方法 | |
| CN115429738B (zh) | 一种祛痘修护焕活精华液及其制备方法 | |
| CN111166707B (zh) | 一种面部抗衰修复护理组合物及其制备方法和应用 | |
| CN109771326A (zh) | 一种用于美白修护面膜的组合物 | |
| CN108245466A (zh) | 一种保湿抗皱面膜及其制备方法 | |
| CN115531281A (zh) | 一种改善皮肤的天然组合物 | |
| CN113350253A (zh) | 一种抗菌止痒滋润养肤沐浴乳及其制备方法 | |
| CN113476385A (zh) | 一种含多种天然植物有效成分的美白益肤温和修复的沐浴凝露及其制备方法 | |
| CN112315881A (zh) | 一种胶原蛋白肽面膜液及其制备方法 | |
| CN111388377A (zh) | 一种烟酰胺原液及其制备方法 | |
| CN108815076A (zh) | 一种美白护肤霜及其制备方法 | |
| CN110934785A (zh) | 一种美白保湿敏感肌肤用洗面奶及其制备方法 | |
| CN105411933A (zh) | 洗发液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210813 |
|
| RJ01 | Rejection of invention patent application after publication |